NCT06085924
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- Pfizer Taiwan Taipei, Taiwan
Clinical trial condition
Explore clinical trials studying COVID-19. Study availability and eligibility vary by location and protocol.
NCT06085924
NCT05648110
NCT07656610
NCT04724720
NCT05268939
NCT05054621
NCT04597047
NCT05506618
NCT04782336
NCT04408066